Inovio Pharmaceuticals, Inc. (INO) Jumps: Stock Rises 12.8% – Tale of the Tape

March 20, 2015 Technicals 0

Zacks

Inovio Pharmaceuticals, Inc. (INO) was a big mover last session, as the company saw its shares rise more nearly 13% on the day. The upside came after the company announced that its Chief Operating Officer, Dr. Niranjan Sardesai, will present at the 3rd Annual Regen Med Investor Day on Mar 25, 2015. The news led to far more shares changing hands than in a normal session, breaking the recent trend of the company, as the stock is now trading above the volatile price range of $6.45 to $8.56 over the past one-month time frame.

The stock has witnessed one upward and two downward estimate revisions in the past 30 days. The Zacks Consensus Estimate, however, has moved up over the same time frame, suggesting that more solid trading could be ahead for Inovio Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if the latest jump can turn into more strength down the road.

Inovio Pharmaceuticals carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

A better-ranked stock in the med-biomed/gene industry is Acorda Therapeutics, Inc. (ACOR), sporting a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply